CASE REPORT

Management of von willebrand disease in pregnancy in resource-limited settings: a case report

I Wayan Losen Adnyana

I Wayan Losen Adnyana
Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Udayana, Bali Indonesia. Email: losenadyana@yahoo.com
Online First: October 30, 2020 | Cite this Article
Adnyana, I. 2020. Management of von willebrand disease in pregnancy in resource-limited settings: a case report. Bali Medical Journal 9(3): 600-602. DOI:10.15562/bmj.v9i3.2044


Background: Von Willebrand's disease (VWD) is the most common autosomal dominant bleeding disorder. Pregnancy and delivery in patient with VWD possess significant clinical challenges.

Case description: a 24-year-old woman who will undergo labor with a history of VWD.  The patient was planned for induction of vaginal delivery and has been given intranasal desmopressin, cryoprecipitate, and factor VIII from before delivery to 5 days after delivery. Labor occurs without excess bleeding. The patient was monitored for 6 days after delivery, and there is no complication of excessive bleeding.

Conclusion: This case emphasizes how to manage Von Willebrand's disease in pregnancy with limitation in the examination and therapeutic option, also the importance of joint management from the hematologist, obstetrician, starting from the antepartum, delivery, and postpartum phases.

References

Leebeek FW, Eikenboom JC. Von Willebrand’s Disease. N. Engl. J. Med. 2016;375(21):2067–80.

Sanders YV, Groeneveld D, Meijer K, et al. Von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease. Blood 2015; 125: 3006-13.

Kouides PA. An update on the management of bleeding disorders during pregnancy. Curr Opin Hematol 2015; 22: 397-405.

Laffan MA, Lester W, O'donnell JS, Will A, Tait RC, Goodeve A, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br. J. Haematol. 2014;167(4):453–65.

National Heart, Lung, and Blood Institute. NHLBI Von Willebrand Disease Expert Panel. The diagnosis, evaluation and management of von Willebrand disease. NIH publication no. 08-5832. Bethesda, Md.: U.S. Department of Health and Human Services; December 2007. http://www.nhlbi.nih.gov/guidelines/vwd/index.htm. Accessed at 1 Juli 2020.

Lipe BC, Dumas MA, Ornstein DL. Von Willebrand Disease in Pregnancy. Hematol. Oncol. Clin. North Am. 2011;25(2):335–58.

Hawke L, Grabell J, Sim W, et al. Obstetric bleeding among women with inherited bleeding disorders: a retrospective study. Haemophilia. 2016;22:906‐911

Castaman G, James PD. Pregnancy and delivery in women with von Willebrand disease. Eur J Haematol. 2019;103(2):73–9.

Reynen E, James P. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion. Semin Thromb Hemost. 2016;42(07):717–23.

Laffan M, Sathar J, Johnsen JM. von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis. Haemophilia. 2020;

Peyvandi F, Kouides P, Turecek PL, Dow E, Berntorp E. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor. Blood Rev. 2019;38:100572.

James AH, Konkle BA, Kouides P, et al. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis. Haemophilia. 2015;21:81‐87


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0